 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Other > SangStat Medical Corporation
 |
SangStat Medical Corporation |
 |
 |
 |
NEWS FROM THE WIRES |
 |
SangStat loss narrows 87 pct as cost cuts kick in Jul 25 2001 01:47 PM PDT
> More WIRE STORIES about this company
PROFILE |
 |
SangStat Medical wants to improve the outcome of organ transplants. Its products include Celsior, which preserves organs prior to transplantation, and Thymoglobulin, which prevents graft rejection in kidney, pancreas, and liver transplants and has applications in bone marrow transplants, as well. In the company's pipeline is RDP58, a treatment for colitis and Crohn's disease. The firm's Transplant Pharmacy, which it has agreed to sell, provides mail-order medicines to transplant patients; TransplantRx.com does the same via the Internet. SangStat has deals with such firms as Amgen and Aventis.
COMPETITION |
 |
Hoffmann-La Roche Inc. (dossier)
Novartis AG (NVS)
Pharmacia Corporation (PHA)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 63.10
1-Yr. Sales Growth: 8.4%
Employees: 287
Revenue per employee: $219,860.63
KEY PEOPLE |
 |
Jean-Jacques Bienaimé
CEO
Stephen G. Dance
CFO
CONTACT INFO |
 |
6300 Dumbarton Circle
Fremont, CA 94555
US
Phone: 510-789-4300
Fax: 510-789-4400
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |